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Ephrin-B2, a member of the Eph/ephrin family of cell signaling molecules, has been implicated in the
guidance of cranial and trunk neural crest cells (NCC) and development of the branchial arches(BA), but
detailed examination in mice has been hindered by embryonic lethality of Efnb2 null loss of function due
to a requirement in angiogenic remodeling. To elucidate the developmental roles for Efnb2, we generated
a conditional rescue knock-in allele that allows rescue of ephrin-B2 speciﬁcally in the vascular en-
dothelium (VE), but is otherwise ephrin-B2 deﬁcient. Restoration of ephrin-B2 expression speciﬁcally to
the VE completely circumvents angiogenic phenotypes, indicating that the requirement of ephrin-B2 in
angiogenesis is limited to the VE. Surprisingly, we ﬁnd that expression of ephrin-B2 speciﬁcally in the VE
is also sufﬁcient for normal NCC migration and that conversely, embryos in which ephrin-B2 is absent
speciﬁcally from the VE exhibit NCC migration and survival defects. Disruption of vascular development
independent of loss of ephrin-B2 function also leads to defects in NCC and BA development. Together,
these data indicate that direct ephrin-B2 signaling to NCCs is not required for NCC guidance, which
instead depends on proper organization of the embryonic vasculature.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
The neural crest (NC) is a population of cells unique to verte-
brates which contributes to the development and ﬁnal composi-
tion of numerous, diverse tissue types. Following their induction,
NCCs delaminate from the ectoderm/neurectoderm boundary and
migrate along highly stereotyped routes dependent on a milieu of
guidance cues to reach their destinations (Bhatt et al., 2013;
Bronner and LeDouarin, 2012; Kulesa and Gammill, 2010). Rostral
to the otic placode, cranial NCCs (CNCCs) are induced prior to
neural tube closure, undergo an epithelial to mesenchymal tran-
sition and acquire a migratory phenotype. In their dorsolateral
route, CNCCs migrate in loosely connected streams that corre-
spond to their ultimate destination and come into intimate contact
with the surface ectoderm and mesodermal cell types such as the
vascular endothelium (VE) as they home toward and ultimatelyinvade the frontonasal mass and branchial arches (BA) (Kulesa
et al., 2010). CNCCs give rise to facial skeleton, connective tissue,
glia, Schwann cells, and ciliary and cranial sensory ganglia and
pigment cells (Bronner and LeDouarin, 2012; Kulesa et al., 2010).
Trunk NCCs also have highly stereotyped migration pathways.
An early intersomitic migrating population of NCC gives rise to the
sympathetic ganglia. Later migrating ventral pathway cells are
segmented by repulsive cues from the caudal somite to migrate
through the rostral somite and also contribute to the sympathetic
ganglia, whereas those that remain in the somite coalesce to form
sensory neurons and glia of the dorsal root ganglia. Finally, NCCs
migrating dorsolaterally give rise to melanocytes (Gammill and
Roffers-Agarwal, 2010). The cardiac crest, which contributes to
heart development, and the vagal and sacral NC, which give rise to
the enteric ganglia of the gut, also exhibit highly regulated mi-
gration patterns. The highly stereotyped migration pattern of the
NCCs is critical to their ultimate fate and function and numerous
signaling molecules have been identiﬁed that can act as guidance
cues in the cranial and trunk regions. Eph receptors and their
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have been implicated in NCC guidance and have established roles
in a variety of other developmental contexts including axon gui-
dance, boundary formation, early morphogenesis, neurogenesis,
and vascular development. Comprising the largest class of receptor
tyrosine kinases, Eph receptors transduce a forward signal by
catalytic activation of their intracellular kinase domains (Kullander
and Klein, 2002). In addition to activating Eph receptor forward
signaling, ephrins also transduce a reverse signal into the cell on
which they are expressed (Bush and Soriano, 2012; Davy and
Soriano, 2005). In the case of the transmembrane B-type ephrins
this is thought to occur principally via tyrosine phosphorylation
and PDZ-binding capacity of the intracellular domain, though
other forms of reverse signaling have also been suggested (Bush
and Soriano, 2012).
Important roles in cranial and trunk NCC guidance have been
attributed to signaling by B-type ephrins in multiple organisms.
Based on overexpression and dominant negative studies in Xe-
nopus, ephrin-B2 expression in the NC and mesoderm of the
second BA (BA2) was proposed to restrict intermingling of second
and third arch NCCs into adjacent regions (Smith et al., 1997). In
the trunk of rat and mouse embryos, ephrin-B2 was found to be
expressed in the caudal half of the somitic sclerotome, and the
EphB2 receptor was detected in NCCs migrating through the ros-
tral half (Davy and Soriano, 2007; Wang and Anderson, 1997). A
similar situation was reported in chick, though in this case it was
ephrin-B1 that was expressed in the caudal sclerotome, com-
plementary to EphB3 expression in the NCCs and the rostral
sclerotome. In explants from rat and chick, NCCs avoided stripes of
B-type ephrin, and when signaling was blocked, they in-
appropriately invaded ephrin-B-expressing territories. These stu-
dies were amongst the ﬁrst to elucidate the repulsive nature of
Eph/ephrin signaling and led to a model wherein repulsive ephrin-
B was involved in the segmental migration of trunk NCCs through
the rostral half of the scleretome (Krull, 1998; Krull et al., 1997;
Wang and Anderson, 1997).
Roles for ephrin-B2 in CNCCs, BA2 morphogenesis and trunk
NCC migration have been supported by phenotypes in mouse
mutants (Adams et al., 2001; Davy and Soriano, 2007), but the
requirement for ephrin-B2 in vascular angiogenesis has compli-
cated detailed analysis of these and other putative Efnb2 loss of
function phenotypes (Adams et al., 1999; Wang et al., 1998).
Ephrin-B2/EphB4 signaling is a critical regulator of vascular mor-
phogenesis, where it is required for angiogenic remodeling of the
primitive capillary plexus into hierarchically branched vessels, and
its complete loss leads to embryonic lethality by E9.5 due to an-
giogenic defects. Ephrin-B2 is highly expressed within the VE and
its conditional loss in this cell type, mediated by Tie2-Cre, also
resulted in angiogenic remodeling defects similar to those found in
Efnb2 homozygous null embryos (Adams et al., 1999; Gerety et al.,
1999; Wang et al., 1998). Ephrin-B2 is also expressed highly in the
BA ectoderm and at lower levels in BA CNCCs (Adams et al., 2001,
1999; Davy and Soriano, 2007; Gerety et al., 1999; Wang et al.,
1998). Whereas null mutation of Efnb2 led to defective CNCC mi-
gration and dysmorphic BA2, a carboxy-terminally truncated re-
verse signaling-dead form of ephrin-B2 was reported to exhibit
normal CNCC migration and BA2 morphogenesis while exhibiting
defective angiogenesis (Adams et al., 2001; Davy and Soriano,
2007). This truncated ephrin-B2 protein may not localize normally
to the plasma membrane, however, and an allele of ephrin-B2 in
which the intracellular domain was instead replaced with β-ga-
lactosidase (Efnb2LacZ) did not display defective angiogenesis, NCC
or BA phenotypes, indicating these processes are most likely
mediated by forward signaling.
Efnb2LacZ/LacZ mice display a variety of defects including cardiac
valve abnormalities, defects in urogenital and anorectaldevelopment, laryngotracheoesophageal cleft, cleft palate, anterior
commissure axon guidance defects, and pulmonary hypoplasia
(Bennett et al., 2013; Cowan et al., 2004; Dravis et al., 2004; Dravis
and Henkemeyer, 2011). Some of these phenotypes, including
hypospadias and cleft palate also occurred in Efnb2LacZ/þ hetero-
zygous embryos, suggesting they may be attributable to gain of
function modes of action (Dravis et al., 2004; Mäkinen et al.,
2005). Indeed, it has been recently shown that Efnb2LacZ/LacZ em-
bryos exhibit elevated phosphorylation of the EphB4 receptor,
raising uncertainty as to which of the reported Efnb2LacZ pheno-
types are attributable to loss of reverse signaling, and which are
attributable to hyperactivation of forward signaling (Zhang et al.,
2015).
To clarify the developmental roles for ephrin-B2 in non-vas-
cular cell types, and particularly in NCC guidance and BA forma-
tion, we have generated a novel Efnb2 conditional rescue mouse
model that maintains the endogenous expression of ephrin-B2 in
the VE, but ablates it in all other tissues. This approach allows the
study of ephrin-B2 loss of function throughout development
without the complications of defective angiogenesis and em-
bryonic lethality. Surprisingly, we ﬁnd that ephrin-B2 expression
in the VE is sufﬁcient to rescue NCC guidance and branchial arch
formation, but is not sufﬁcient for normal tracheoesophageal, ur-
ogenital, or thymus development. Interestingly, conditional loss of
ephrin-B2 speciﬁcally in the VE also leads to NCC and branchial
arch phenotypes associated with reduced survival of the NCCs.
These data clarify the roles of ephrin-B2 during development and
suggest that the circulatory function conferred by proper angio-
genic remodeling and possibly signaling from the VE is critical for
normal NCC migration and branchial arch development.2. Materials and methods
2.1. Mice
The Efnb2CR targeting construct included in 5′-to-3′ order: a
1910 bp EcoRV/XbaI 5'-homology arm including the ﬁrst exon of
Efnb2, a LoxP-ﬂanked adenoviral splice acceptor sequence-
H2BCherry-triple polyA signal cassette, a FRT-ﬂanked PGKNEO-
positive selection cassette, a 4,018 bp XbaI 3′ homology arm and a
pGKDTAbpA-negative selection cassette (Fig. S1A). This construct
was electroporated into 129S4 AK7.1 ES cells and targeting was
initially screened with a forward PCR primer located upstream of
the 5′ arm with sequence 5′-CCAAACCAATTCGTAGTTGCAG-3′ and
a reverse primer corresponding to the 5′ end of the genetrap
cassette with sequence 5′-GACCGCGAAGAGTTTGTCCTC-3′ which
ampliﬁed a band of 2304 bp from targeted clones. PCR-positive ES
cell clones were screened by Southern hybridization with 5′ and 3′
external genomic and Neo internal probes to ensure single tar-
geted insertion. The 5’ probe was a 397 bp sequence ampliﬁed by
PCR with a sense primer 5’-CATTATTGCCCTGAGAGATGCC-3’ and
reverse primer 5′CTTTAACAGATAGGGCTGAGGG-3′ used to screen
ES cell DNA digested with Asp718 and HindIII. The 3’ probe was a
315 bp sequence ampliﬁed by PCR with a forward primer
5-GGCTGTTTGGTTATGTGAGAGC-3’ and reverse primer 5′GCCCA-
AATAGATGAAGGCAAGG-3’ used to screen ES cell DNA digested
with Asp718 and EcoRV. Screening 132 ES cell clones resulted in 10
strong PCR positive correctly targeted ES cell clones ﬁve of which
were injected into C57Bl/6 J blastocysts resulting in nine high-
percentage male chimeras. These chimeras were bred to wild-type
or ROSA26FlpO/FlpO females (Raymond and Soriano, 2007) in the
129S4 co-isogenic background to remove the Frt-ﬂanked NEO
cassette and conﬁrmed by PCR. Two mouse lines from in-
dependent ES cell clones were found to be phenotypically indis-
tinguishable. Mice were then crossed 5 or more generations to the
Fig. 1. The Efnb2CR allele facilitates tissue-speciﬁc Cre-dependent maintenance of ephrin-B2 expression. (A) Schematic illustrating the structure of the Efnb2CR splice trap
before and after Cre-mediated recombination compared to the wild-type Efnb2. Purple lines represent mRNA splicing. (B–F) Unstained embryos at E9.75 of indicated
genotypes. Embryos with global (E) and endothelial (F) rescued ephrin-B2 expression and controls (B) develop normally whereas Efnb2CR/CR (C) or Efnb2CR/GFP (D) mutants do
not. (G–K) In situ hybridization against Efnb2 on cryosections of E9.75 embryos of indicated genotypes with insets of the mandibular component of the ﬁrst branchial arch.
Embryos with globally rescued ephrin-B2 (J) show a normal Efnb2 expression pattern when compared to positive (G) and negative (H–I) controls, whereas endothelial
rescued embryos (K) show Efnb2 expression restricted to the endothelium, indicated by the black arrow. Scale bars: B–F 500 μm, G–K 200 μm, G′–K′ 50 μm.
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Genotyping was performed using standard PCR protocols on
yolk sacs of embryos up through E12.0 and tail snips thereafter.
Detection of Efnb2CR and recombined Efnb2CRΔ was achieved by
PCR with an annealing temperature of 58 °C for 30 cycles pairing
primers 5′-GGCCTTGGACCCTGTTTCTAG-3′ (forward) with 5′-
GACCGCGAAGAGTTTGTCCTC-3′ (reverse) or 5′-CGGACATGTACA-
GAGCTCGAG-3′ (reverse), respectively yielding bands of 213 bp
and 120 bp. Efnb2þ , as distinct from Efnb2GFP, Efnb2CR and
Efnb2CRΔ, was detected by PCR with an annealing temperature of
61 °C for 35 cycles using primers 5′-TAAGTGGTGTCCACGAGCC-3′
(forward) and 5′-GAGCCTAATTAGAGTACCCTTGG-3′ (reverse),
yielding a band of 206 bp.
The following pre-existing lines were used in conducting this
work: Actin-CreTg (MGI:2176050), Efnb2GFP (MGI:3526818), Efnb2lox
(MGI:2176538), Ephb4ap, Ephb4tauLacZ (MGI:2183162), Ncx1lacZ
(MGI:2384543) and Tie2-CreTg (MGI:3608912).2.2. Histology, immunoﬂuorescence and in situ hybridization
Embryos for histology were ﬁxed in Bouin's ﬁxative for a
minimum of three days, processed into and embedded in parafﬁn,
cut at a thickness of 7 μm and stained with hematoxylin and eosin
following standard protocols. Embryos for whole mount protocols
were ﬁxed overnight in 4% PFA in PBS at 4 °C, graded into me-
thanol and stored at 20 °C. Embryos for cryosectioning were
ﬁxed identically, graded into 25% sucrose in PBS, embedded in
OCT, stored at 80 °C, cut at a thickness of 10–12 μm and stored
with desiccant at 20 °C.
Immunostaining was performed using antibodies recognizing
cleaved Caspase3 (1:800, Cell Signaling #9664), CD31 (1:150, BD
Pharmingen #553370), GFP (1:800, Abcam #ab13970), Neuroﬁla-
ment 2H3 (1:250, DSHB 2H3) and Sox10 (1:75, Santa Cruz Bio-
technologies #sc-17342). Both section and whole mount im-
munostainings were performed according to standard protocols.
Sections were imaged either by epiﬂuorescence microscopy or by
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optically cleared either by grading into 80% glycerol or according
to the SeeDBp protocol as described (Ke et al., 2013). Imaging was
subsequently performed by laser scanning confocal microscopy or
by spinning disk confocal microscopy. Z-stacks obtained by con-
focal microscopy were condensed into 2-dimensional images in
Fiji (ImageJ) using the standard deviation method within the Z
projection function.
Section and whole mount in situ hybridization were performed
according to standard protocols. The Efnb2 in situ probe hybridizes
to a region spanning from an XbaI site (position 538) to a PstI site
(position 1056) on the Efnb2 mRNA (RefSeq NM_010111.5); this
region, spanning exons 2-5, would be absent from the splice-
trapped Efnb2CR mRNA. The Sema3F in situ probe hybridizes to a
region spanning from an ApaI site (position 186) to a PstI site
(position 1219) on the Sema3F mRNA (RefSeq NM_011349). The
Sox10 in situ probe has been previously described (Kuhlbrodt et al.,
1998).3. Results
In order to study the developmental roles of ephrin-B2 outside
of the VE, we generated a conditional rescue allele of Efnb2
(Efnb2CR) which expresses fully-functional ephrin-B2 only upon
Cre-mediated recombination. Brieﬂy, this allele was a gene tar-
geted insertion into the ﬁrst intron of Efnb2 with a cassette con-
taining a strong splice acceptor and a triple polyadenylation signal,
all ﬂanked by LoxP sites (Fig. 1A, Supp. Fig. 1). To verify that the
Efnb2CR allele functioned as a null loss of function allele in the
absence of Cre, we compared it to a previously-generated Efnb2GFP
null allele that expresses a fusion of the histone 2B and GFP pro-
teins from the endogenous Efnb2 locus (Davy and Soriano, 2007).
Efnb2CR/CR E9.75 homozygous embryos completely lacked Efnb2
mRNA expression and were alive with beating hearts, though they
were growth retarded and displayed enlarged pericardia and
dysmorphic branchial arches and frontonasal mass. These were
embryonic lethal at midgestation, indistinguishable from Efnb2CR/
GFP embryos and identical to what has been previously reported for
Efnb2GFP/GFP (Fig. 1C–D,H–I,H′–I′) (Davy and Soriano, 2007). To
verify Cre-dependent rescue in this allele, we utilized the ubiqui-
tously expressing β-Actin-Cre transgene to generate embryos with
global rescue of ephrin-B2 (Lewandoski et al., 1997). As expected,
E9.75 Efnb2CR/GFP; β-Actin-CreTg/þ embryos displayed restoration of
Efnb2 mRNA expression in all contexts as well as complete phe-
notypic rescue, indistinguishable from controls (Fig. 1B,E,G,G′,J,J′).
We next reasoned that since conditional loss of ephrin-B2 in the
VE results in angiogenic phenotypes similar to those in Efnb2null
embryos, expression of ephrin-B2 solely in the VE may also be
sufﬁcient for normal vascular angiogenesis (Gerety and Anderson,
2002). To test this hypothesis, we utilized Tie2-Cre transgenic mice,
in which Cre-recombinase is expressed speciﬁcally in the VE, to
generate Efnb2CR/GFP; Tie2-CreTg/þ embryos (Braren et al., 2006). As
intended, these embryos exhibited rescued expression of Efnb2
mRNA speciﬁcally within the VE, and lacked expression in other
cell types in which it would normally be expressed (Fig. 1G,K;
Supp. Fig. 2), including branchial arch ectoderm, endoderm, me-
soderm and NCCs (Fig. 1G′,K′). These embryos appeared overtly
normal at E9.5, without signs of angiogenic defects (Fig. 1F,K,K′).
To verify that the endothelial rescue of ephrin-B2 restored normal
angiogenesis, we performed whole-mount immunostaining for
CD31 on Efnb2CR/GFP; Tie2-CreTg/þ mutants at E9.5. Whereas
Efnb2CR/GFP embryos failed to undergo proper angiogenesis, the
remodeling of the primitive vascular plexus into hierarchically
branched vessels was similar in Efnb2CR/GFP; Tie2-CreTg/þembryos
compared to wild-type control (Fig. 2A–C; Supp. Fig. 5A,B,J,K).Together, these data indicate the Efnb2CR allele faithfully allows the
tissue-speciﬁc, Cre-conditional rescue of ephrin-B2 expression
under its endogenous promoter allowing us to assess loss of
function phenotypes outside of vascular development.
Efnb2CR/GFP; Tie2-CreTg/þ embryos survived to birth, but died
perinatally. Previous studies have suggested roles for Efnb2 in
secondary palate development, tracheoesophageal and urorectal
septation, and normal positioning of the thymus (Dravis et al.,
2004; Dravis and Henkemeyer, 2011; Foster et al., 2010). Ex-
amination of these structures in E15.5 histological sections re-
vealed that indeed Efnb2CR/GFP; Tie2-CreTg/þ mutants exhibit tra-
cheoesophageal and urorectal ﬁstulae as well as an incorrectly
positioned thymus (Table 1; Supp. Fig. 3C–J). Other bilateral
structures such as the lungs, vena cava and clavicles were com-
parable between control and Efnb2CR/GFP; Tie2-CreTg/þ mutant
embryos and examination of adjacent sections conﬁrmed that
thymus mispositioning was not attributable to variable or asym-
metric planes of section. These phenotypes are consistent with
what has been previously reported in other Efnb2 mutant mouse
models (Dravis et al., 2004; Dravis and Henkemeyer, 2011; Foster
et al., 2010). We did not, however, observe cleft palate in Efnb2CR/
GFP; Tie2-CreTg/þ embryos (0/7 embryos) (Table 1, Supp. Fig. 3A–B),
despite complete loss of Efnb2 from the palatal shelves (Supp.
Fig. 2A–B).
We next sought to utilize this tool to investigate the roles of
ephrin-B2 in NCC guidance and BA morphogenesis without com-
plications from angiogenic phenotypes. We and others have ob-
served that Efnb2null embryos exhibit hypoplastic mandibular and
second branchial arches (Fig. 1 C,D; Fig. 2 E,F,I,J) (Adams et al.,
2001; Davy and Soriano, 2007). Based on immunostaining for
Sox10, CNCC migration was perturbed in Efnb2CR/GFP null E9.5
embryos, with reduced and disorganized trigeminal NCC streams
that failed to properly enter BA1 (Fig. 2 E,F, white arrows). In
general, BA2 NCC streams were less dramatically affected than the
trigeminal streamwith the shape of the stream typically appearing
thinner but intact (Fig. 2 E,F,I,J white arrows). Sox10 expression is
progressively restricted to the condensing cranial ganglia and in-
deed, immunostaining of Efnb2CR/GFP null embryos with the anti-
neuroﬁlament (2H3) antibody conﬁrmed defects in these cells
(Supp. Fig. 4 A–B′). To determine if other NCC populations were
also affected, we examined the expression of pan-NCC marker
Crabp1 by in situ hybridization in E9.5 Efnb2CR/GFP null embryos
and found reduced trigeminal and BA2 NCC streams as well as less
abundant Crabp1 positive NCCs populating the ﬁrst and second
branchial arches (Supp. Fig. 4C,D). Immunostaining of E9.0 (12ss)
Efnb2CR/GFP null embryos for Sox10 revealed that initial CNCC
emigration and guidance were overtly normal, but by E9.25 (16ss),
Efnb2CR/GFP null embryos began to exhibit a thinner trigeminal NCC
stream (Supp. Fig. 5). Notably, the appearance of this phenotype
correlated with the initial appearance of defects in vascular pat-
terning. These data are consistent with what has been published
previously for Efnb2null embryos, and demonstrate that global loss
of Efnb2 has substantial consequences for BA and CNCC
development.
It has been reported that loss of ephrin-B2 also leads to dis-
ruption, but not complete loss, of segmental migration of trunk
NCCs that parallels defects in somite polarity and perturbed so-
mitic expression of Sema3F, a gene that is required for NCC gui-
dance (Davy and Soriano, 2007; Gammill et al., 2006). In situ hy-
bridization for Sox10 in E9.5 (23-25ss) Efnb2CR/GFP null embryos
revealed reduced and disorganized TNCC migratory streams with
variably perturbed interspacing when compared with controls;
these streams were often associated with smaller and dis-
organized somites, possibly contributing to apparent TNCC phe-
notypes (Fig. 3A–B,A′-B′; Fig. 4E,F; Fig. 5J,L). TNCC streams in the
more posterior embryo could not be identiﬁed at all in Efnb2CR/GFP
Fig. 2. Ephrin-B2 expression in the vascular endothelium is necessary and sufﬁcient to allow normal CNCC migration and BA morphogenesis. (A–H) Whole mount co-
immunostain against the endothelial marker CD31 (A–D) and a marker of migratory neural crest Sox10 (E–H) with channels merged (I–L) in E9.5 embryos of the indicated
genotypes. Embryos with endothelial rescue of ephrin-B2 (C) undergo angiogenic remodeling, hierarchical branching shown by arrows, similarly to controls (A), whereas
embryos with endothelial deletion of ephrin-B2 (D) and Efnb2null embryos (B) fail to do so. Conversely, endothelial ablation of ephrin-B2 (H) and Efnb2null (F) embryos exhibit
defects in neural crest migration, shown by white arrows, and dysmorphic branchial arches, shown by white arrowheads, in contrast to endothelial rescue of ephrin-B2
(G) and control (E) embryos which display normal neural crest migration and branchial arch morphogenesis. Scale bars: 200 μm.
Table 1
Summary of Efnb2CR/GFP; Tie2-CreTg/þ phenotypes.
Phenotype Incidence in Efnb2CR/GFP; Tie2-CreTg/þ
embryos
Defective NCC migration 0/11
Branchial arch dysmorphogenesis 1/35
Tracheoesophageal ﬁstula 12/12
Urorectal ﬁstula 3/3
Thymus mislocalization 5/5
Cleft palate 0/7
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initial intersomitic migration of TNCCs at this position (Supp.
Fig. 6A,B). In addition, immunostaining for neuroﬁlament revealed
that initiation of the dorsal root ganglia was disrupted in Efnb2CR/
GFP null mutants (Fig. 4A,B). However, somite polarity appeared
unperturbed in Efnb2CR/GFP null embryos as assessed by analysis of
ephrin-B2-GFP, which exhibited elevated expression in the caudal
halves of somites that was comparable to control (Fig. 4E,F). We
did not observe differences in Sema3F expression, in Efnb2CR/GFPnull embryos, suggesting this may not be the cause of TNCC de-
fects (Fig. 4I,J).
Surprisingly, Efnb2CR/GFP; Tie2-CreTg/þ embryos did not exhibit
defects in BA morphogenesis or cranial or trunk neural crest de-
velopment (Fig. 1F,K,K’; Fig. 2G,K; Fig. 3C,C’; Fig. 4C,G,K; Supp.
Fig. 6C), indicating that expression of ephrin-B2 in the VE alone is
sufﬁcient to allow proper NCC development. We therefore next
asked whether ephrin-B2 expression in the VE was necessary for
normal NCC and branchial arch development. We generated
Efnb2lox/lox; Tie2-CreTg/þ embryos, which are known to be em-
bryonic lethal due to angiogenic failure (Fig. 2D; Supp. Fig. 5C,L)
(Gerety and Anderson, 2002), but have not been examined for NCC
migration phenotypes. Interestingly we found that at E9.5, in ad-
dition to failed angiogenesis, these mutants displayed dysmorphic
branchial arches and defective cranial and trunk NCC migration
similar to Efnb2CR/GFP null embryos (Fig. 2D,H,L; Fig. 3D,D’; Fig. 4D;
Supp. Fig. 5F,R; Supp. Fig. 6D). Also similar to Efnb2CR/GFP null
embryos, loss of ephrin-B2 from the VE in Efnb2GFP/lox; Tie2-CreTg/þ
did not result in defects in somite polarity or Sema3F expression
(Fig. 4H,L). Together, these results indicate that expression of
ephrin-B2 in the VE is necessary and sufﬁcient to allow normal
Fig. 3. Ephrin-B2 expression in the vascular endothelium is necessary and sufﬁcient to allow normal trunk NCC migration. (A–D) Whole mount in situ hybridization against
Sox10 in E9.75 embryos of the indicated genotypes with high magniﬁcation of the trunk on the contralateral side. Embryos with endothelial rescue of ephrin-B2 (C) exhibit a
migratory neural crest pattern comparable to controls (A), whereas Efnb2null embryos (C) and Efnb2lox/lox; Tie2-CreTg/þ embryos with endothelial deletion of ephrin-B2 (D) and
display defective cranial neural crest migration and a disorganization of the trunk neural crest. Asterisks indicate the position of the limb bud. Scale bars: A–D 500 μm, A′–D′
200 μm.
A.E. Lewis et al. / Developmental Biology 406 (2015) 186–195 191NCC migration and branchial arch morphogenesis.
We next asked whether loss of ephrin-B2 from the VE affected
cell survival, either generally throughout the embryo or speciﬁ-
cally within the NCCs. Immunostaining for Sox10 and cleaved
Caspase3 in frontal sections of Efnb2CR/GFP null and Efnb2lox/lox;
Tie2-CreTg/þ embryos showed elevated cell death in the dorsal
neural tube and migratory NCCs compared to control (Fig. 5 A,B,D,
A′,B′,D′). Whole mount immunostaining of Efnb2CR/GFP null em-
bryos and Efnb2GFP/lox; Tie2-CreTg/þ embryos revealed striking
elevation of cleaved Caspase3 within the migratory streams of the
CNCCs indicating that CNCCs are sensitized to loss of ephrin-B2
from the VE (Fig. 5 E,F,H). Additionally, the trunk displayed
widespread cell death which was associated with, but not re-
stricted to, TNCCs and somites (Fig. 5 I,J,L,M,N,P). Apoptosis in the
trunk was largely excluded from the VE, however, indicating that
effects on cell survival were not autonomous to the vasculature
(Fig. 5 Q,R,T). Again, Efnb2CR/GFP; Tie2-CreTg/þ embryos did not
present any of these anomalies (Fig. 5C,C′,G,K,O,S), indicating that
ephrin-B2 expression in the VE alone is necessary and sufﬁcient to
allow normal NCC survival.
The delimited requirement for ephrin-B2 in the VE for NCC and
BA development could be attributable to a requirement of the
vasculature to deliver oxygen or other nutrients and signalingmolecules to the embryo, or could suggest active signaling from
ephrin-B2 in the VE to the NCCs. Homozygous null mutation of
Ephb4 results in angiogenic remodeling phenotypes very similar to
those found in Efnb2null embryos (Adams et al., 1999; Gerety et al.,
1999) (Fig. 6 C) Examining Ephb4-/- embryos also revealed bran-
chial arch hypoplasia and reduced cranial and trunk NCC migra-
tion very similar to Efnb2CR/GFP embryos indicating that EphB4 was
relevant to these phenotypes (Fig. 6 A,E,G). Because it has been
previously reported that EphB4 expression is highly restricted to
the VE and is not expressed in the NCCs (Gerety et al., 1999; Kim
et al., 2008), we therefore surmise that ephrin-B2/EphB4 signaling
from the VE to the NCCs is not likely to underly these phenotypes.
To determine whether NCC and BA defects are general features of
angiogenic failure, we turned to an independent regulator of an-
giogenesis. The Ncx1 gene encodes a calcium transport channel
expressed solely in the heart at E9.5, which is necessary for heart
contraction and therefore for proper blood ﬂow. In Ncx1 knockout
mouse embryos, a primitive vascular plexus is formed, but does
not undergo remodeling (Fig. 6D), though other aspects of devel-
opment, such as limb morphogenesis appear normal until death of
the embryo (Koushik et al., 2001; Wakimoto et al., 2000). Notably,
Ncx1-/- embryos exhibited defective BA and NCC development and
NCC survival phenotypes that were again similar to Efnb2CR/GFP
Fig. 4. Loss of ephrin-B2 does not affect somite polarity. (A–H) Whole mount co-immunostain against neuroﬁlament (2H3) (A–D) and ephrin-B2-GFP (E–H) in E9.5 embryos
of the indicated genotypes. Efnb2null embryos (B) and embryos with endothelial deletion of Efnb2 (D) fail to initiate DRG morphogenesis, in contrast to embryos with
endothelial rescue of Efnb2 (C) and controls (A). (I–J) Whole mount in situ hybridization for Sema3F on E9.5 embryos of the indicated genotypes. Asterisks indicate the
forelimb bud position. Scale bars: 200 μm.
A.E. Lewis et al. / Developmental Biology 406 (2015) 186–195192homozygous loss of function (Fig. 6 B,F,H; Supp. Fig. 7), indicating
that proper angiogenesis is particularly required for NCC and BA
development.4. Discussion
Here we clarify the extravascular developmental roles for Efnb2
by the generation of a novel conditional rescue mouse line. Though
we ﬁnd no evidence for a requirement for ephrin-B2 in secondary
palate development, we do ﬁnd that loss of function of ephrin-B2
results in defective tracheoesophageal and urorectal septation as
reported for the Efnb2LacZ intracellular substitution allele (Cowan
et al., 2004; Dravis et al., 2004; Dravis and Henkemeyer, 2011). In-
terestingly, whereas 16% of Efnb2LacZ/þ embryos exhibited urorectal
defects, 71% of ephrin-B2LacZ/ΔV mutants had this phenotype, sug-
gesting that the PDZ-domain binding capacity of ephrin-B2 was
involved in this context (Dravis and Henkemeyer, 2011). All of the
Efnb2CR/GFP; Tie2-CreTg/þ mutants we examined exhibited tracheoe-
sophageal (12/12) and urorectal (3/3) phenotypes, supporting the
notion that these Efnb2LacZ phenotypes are consequences of bona
ﬁde loss of function of reverse signaling. Together with the absence
of such phenotypes in Efnb26YFΔV/6YFΔV or Efnb2ΔV/ΔV mutant em-
bryos, these data support the notion of phosphorylation and PDZ-
independent modes of reverse signaling (Bush and Soriano, 2012;
Dravis and Henkemeyer, 2011; Mäkinen et al., 2005; Thakar et al.,
2011).
Surprisingly, ephrin-B2 expression in the branchial arch ecto-
derm or somites is not required for proper NCC migration. It is
possible that NCC guidance could be provided by redundant sig-
naling from ephrin-B1. Though ephrin-B1 is not highly expressed
in the branchial arch ectoderm in the E9.5 head, it is expressed in
caudal half somites and could potentially provide a repulsive sig-
nal redundant to ephrin-B2 (Wang and Anderson, 1997). Loss of
function of ephrin-B1 alone within the neural crest resulted in
defects in migration of BA3 and BA4 NCCs, but no defects in TNCCs
and compound Efnb1þ /; Efnb2þ /GFP double heterozygous em-
bryos did not exhibit defects in trunk NCC migration or somite
development, though loss of ephrin-B1 and ephrin-B2 in thesomite has not yet been reported. (Davy et al., 2004; Davy and
Soriano, 2007). Such compensation is apparently not at play for
the BA or CNCC phenotypes that arise from loss of ephrin-B2 alone
in Efnb2 / embryos, however. Complete loss of segmental mi-
gration of trunk NCCs in mutant mice with disrupted Neuropillin2/
Semaphorin3F signaling indicates that this pathway may be suf-
ﬁcient to provide repulsive guidance from the caudal scleretome
(Gammill et al., 2006; Gammill and Roffers-Agarwal, 2010),
and might explain why repulsive signaling from ephrin-B2 is dis-
pensable. On the other hand, it is also possible that reducing
Neuropilin/Semaphorin signaling, for example in a Sema3Fþ /;
Efnb2þ / trans-heterozygote, may sensitize the embryo and reveal
requirements for ephrin-B2 in this process. We do not ﬁnd any
evidence of perturbed Sema3F expression in any of our Efnb2
mutant genotypes, suggesting that this is not the cause of the
trunk NCC defects that we observe. Whereas, segmental TNCC
migration defects and Sema3F expression changes were variable in
severity in a previous report, in our study, embryos with expres-
sion of ephrin-B2 in the VE alone never exhibit defects in TNCCs.
Taken together, these data indicate expression of ephrin-B2 in the
somite is not responsible, directly or indirectly, for the proper
pattern of neural crest migration.
Instead, we provide evidence indicating endothelial ephrin-B2
is both necessary and sufﬁcient to allow normal NCC migration
and branchial arch development. Other recent studies have sug-
gested that VE-NCC signaling might be important for NCC mor-
phogenesis. Knockout of Flk1 in the VE led to CNCC migration
defects and death in the absence of generalized hypoxia, possibly
attributable to disrupted Tgfβ signaling (Milgrom-Hoffman et al.,
2014). This study suggested that in addition to roles in perfusion of
the embryo, the VE had a differential requirement for maintaining
CNCCs but not pharyngeal mesoderm markers. Further, explant
cultures were performed to minimize the impact of loss of circu-
lation and hypoxia; under these conditions, disrupted angiogen-
esis and reduced endothelial cells still resulted in failed CNCC
migration. Our data is consistent with this view, as CNCCs in
Efnb2CR/GFP; Tie2-CreTg/þ embryos showed reduced survival com-
pared with other cell types in the embryo, even when the heart
was still beating. Why CNCCs exhibit elevated apoptosis relative to
Fig. 5. Elevated apoptosis in the CNCC in the absence of vascular endothelial ephrin-B2. (A-D’) Immunostaining for cleaved Caspase3 and Sox10 on cryosections of E9.75
embryos of indicated genotypes and high magniﬁcation insets. Efnb2null embryos (B) and Efnb2GFP/lox; Tie2-CreTg/þ embryos with endothelial deletion of ephrin-B2 (D) exhibit
large amounts of cell death localized to the migratory and post-migratory CNCCs compared with control (E) or Efnb2CR/GFP; Tie2-CreTg/þ embryos with expression of ephrin-
B2 only within the VE (G). In the trunk region elevated apoptosis is also associated with, but not limited to migratory NCCs in Efnb2null embryos (J,N,R), or Efnb2GFP/lox; Tie2-
CreTg/þwith deletion of ephrin-B2 from the VE (L,P,T) compared to control (A) or Efnb2CR/GFP; Tie2-CreTg/þembryos with expression of ephrin-B2 only within the VE (G,K,O,S).
Asterisks indicate forelimb bud. Scale bars: A–D 100 μm, A′–D′ 25 μm, E–L 200 μm, M–T 100 μm.
A.E. Lewis et al. / Developmental Biology 406 (2015) 186–195 193other cell types under these conditions is a question for further
study, but previous work in a mouse model of the neurocristo-
pathy Treacher Collins found that the neuroepithelium and early
neural crest are highly sensitive to cellular stress possibly due to
the high metabolic requirement of these cells (Jones et al., 2008). It
is possible, therefore, that angiogenic defects deprive NCCs of
nutrition required to satisfy their metabolic requirements.
In Efnb2 mutant embryos, the trigeminal stream consistently
exhibited more severe defects than BA2 NCCs; this could be cor-
related with the effective stage of NCC migration because this
occurs in a rostral-caudal progression. Indeed, defects in trigem-
inal NCCs were not apparent at 12ss but were by 16ss, whereas
BA2 defects were not apparent at 16ss but manifested by 20ss. We
do not expect that BA dysmorphogenesis and disrupted NCCmigration phenotypes are caused by defective ephrin-B2/EphB4
signaling between VE and CNCCs because previous studies have
indicated that EphB4 expression is restricted to the VE at these
stages and is not expressed in the NCCs (Gerety et al., 1999; Kim
et al., 2008). Rather, we conclude that failed angiogenesis in
ephrin-B2 mutant embryos leads to perturbed NCC migration and
survival either by depriving NCCs of oxygen and other nutrients or
possibly by disrupted signaling from the VE through other
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